BCL2 and acute myeloid leukemia: Since complex I deficiency has been reported to inhibit the release of cytochrome c and apoptosis-inducing factor, resistance to IACS-010759 may become a problem in AML.349 Fortunately, the selective Bcl-2 inhibitor, venetoclax, promotes cytochrome c release because of the tight regulation by this antiapoptotic protein.